{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:36:25Z","timestamp":1787877385223,"version":"build-2784847793"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>S\u00e9zary syndrome (SS) is a rare and aggressive type of cutaneous T-cell lymphoma (CTCL). Due to its rarity and marked biological heterogeneity, SS diagnosis is frequently delayed, as it requires the integration of multiple complex diagnostic tests interpreted by highly specialized biomedical figures. In this context, we investigated the expression of CXCL13\u2014increasingly implicated in several inflammatory and neoplastic skin disorders\u2014as a potential screening biomarker to discriminate SS from mycosis fungoides (MF), the most common CTCL subtype, and from clinically overlapping inflammatory skin diseases, i.e. atopic dermatitis (AD), psoriasis (PS) and eczema (EC). Real-time PCR analysis of CXCL13 mRNA expression in 51 samples showed a significant upregulation in peripheral blood mononuclear cells (PBMCs) from SS patients compared with MF, AD and healthy donors (HD). Protein-level analysis in a larger cohort (n = 142), including allergic and atopic EC patients, revealed significantly higher plasma CXCL13 concentrations in SS than in all other conditions and HD, as assessed by ELISA. Receiver operating characteristic (ROC) analysis confirmed the excellent performance of plasma CXCL13 as a differential marker (AUC = 93%). In contrast, CXCL13 immunohistochemical expression in skin biopsies was broadly detected across all conditions, limiting its diagnostic value. In conclusion, quantification of CXCL13 expression in PBMCs and, more robustly, measurement of its plasma levels by widely available techniques such as RT-qPCR and ELISA may represent practical screening tools to identify patients with suspected SS. These assays could facilitate earlier referral to specialized centres for confirmatory testing and prompt initiation of appropriate therapy.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1804103","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T06:02:34Z","timestamp":1775800954000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["CXCL13 as a simple and promising blood biomarker for differentiating S\u00e9zary syndrome from mycosis fungoides and other confounding chronic inflammatory skin diseases"],"prefix":"10.3389","volume":"17","author":[{"given":"Giulia","family":"Salvatore","sequence":"first","affiliation":[{"name":"Laboratory of Molecular Oncology, Istituto Dermopatico dell\u2019Immacolata IDI-IRCCS","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ylenia Aura","family":"Minaf\u00f2","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Oncology, Istituto Dermopatico dell\u2019Immacolata IDI-IRCCS","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoletta","family":"Croce","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Oncology, Istituto Dermopatico dell\u2019Immacolata IDI-IRCCS","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Passarelli","sequence":"additional","affiliation":[{"name":"Pathology Unit, Istituto Dermopatico dell\u2019Immacolata IDI-IRCCS","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Cristofoletti","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Oncology, Istituto Dermopatico dell\u2019Immacolata IDI-IRCCS","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Cristina","family":"Picchio","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Oncology, Istituto Dermopatico dell\u2019Immacolata IDI-IRCCS","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Bonmassar","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Oncology, Istituto Dermopatico dell\u2019Immacolata IDI-IRCCS","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Madonna","sequence":"additional","affiliation":[{"name":"Laboratory of Experimental Immunology, Istituto Dermopatico dell\u2019Immacolata IDI-IRCCS","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Mercurio","sequence":"additional","affiliation":[{"name":"Laboratory of Experimental Immunology, Istituto Dermopatico dell\u2019Immacolata IDI-IRCCS","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Monopoli","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Istituto Dermopatico dell\u2019Immacolata IDI-IRCCS","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filomena","family":"Russo","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Istituto Dermopatico dell\u2019Immacolata IDI-IRCCS","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaia","family":"Moretta","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Istituto Dermopatico dell\u2019Immacolata IDI-IRCCS","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Scala","sequence":"additional","affiliation":[{"name":"Clinical and Laboratory Molecular Allergy Unit, Istituto Dermopatico dell\u2019Immacolata IDI-IRCCS","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"D\u2019Atri","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Oncology, Istituto Dermopatico dell\u2019Immacolata IDI-IRCCS","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Narducci","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Oncology, Istituto Dermopatico dell\u2019Immacolata IDI-IRCCS","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.19647","article-title":"Improving disease-specific survival for patients with Sezary syndrome in the modern era of systemic therapies","volume":"205","author":"Campbell","year":"2024","journal-title":"Br J Haematol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-11-881268","article-title":"The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas","volume":"133","author":"Willemze","year":"2019","journal-title":"Blood"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1141108","article-title":"Mycosis fungoides and S\u00e9zary syndrome: clinical presentation, diagnosis, staging, and therapeutic management","volume":"13","author":"Miyashiro","year":"2023","journal-title":"Front Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2016.01.038","article-title":"Evaluation of Immunophenotypic and molecular biomarkers for S\u00e9zary syndrome using standard operating procedures: A multicenter study of 59 patients","volume":"136","author":"Boonk","year":"2016","journal-title":"J Invest Dermatol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1001\/archdermatol.2012.2089","article-title":"Differential expression of programmed death-1 (PD-1) in S\u00e9zary syndrome and mycosis fungoides","volume":"148","author":"\u00c7etin\u00f6zman","year":"2012","journal-title":"Arch Dermatol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2","DOI":"10.21037\/cco.2018.11.02","article-title":"S\u00e9zary Syndrome, recent biomarkers and new drugs","volume":"8","author":"Cristofoletti","year":"2019","journal-title":"Chin Clin Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-0148","article-title":"Single-cell lymphocyte heterogeneity in advanced cutaneous T-cell lymphoma skin tumors","volume":"25","author":"Gaydosik","year":"2019","journal-title":"Clin Cancer Res"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.b.21878","article-title":"Flow cytometric evaluation of peripheral blood for suspected S\u00e9zary syndrome or mycosis fungoides: International guidelines for assay characteristics","volume":"100","author":"Horna","year":"2021","journal-title":"Cytometry B Clin Cytom"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-3185","article-title":"Usefulness of KIR3DL2 to diagnose, follow-up, and manage the treatment of patients with S\u00e9zary syndrome","volume":"23","author":"Hurabielle","year":"2017","journal-title":"Clin Cancer Res"},{"key":"B10","doi-asserted-by":"publisher","first-page":"adv00773","DOI":"10.2340\/actadv.v102.1062","article-title":"A high programmed cell death protein 1 hormone receptor score on skin biopsy is associated with S\u00e9zary syndrome diagnosis: A study of 91 patients with erythroderma","volume":"102","author":"Luherne","year":"2022","journal-title":"Acta Derm Venereol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/35018581","article-title":"A chemokine-driven positive feedback loop organizes lymphoid follicles","volume":"406","author":"Ansel","year":"2000","journal-title":"Nature"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00471","article-title":"CXCL13 and its receptor CXCR5 in cancer: inflammation, immune response, and beyond","volume":"10","author":"Kazanietz","year":"2019","journal-title":"Front Endocrinol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.21791","article-title":"Primary cutaneous peripheral T-cell lymphomas with a T-follicular helper phenotype: an integrative clinical, pathological and molecular case series study","volume":"187","author":"Wang","year":"2022","journal-title":"Br J Dermatol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201801416R","article-title":"The cytokine environment influence on human skin-derived T cells","volume":"33","author":"Kienzl","year":"2019","journal-title":"FASEB J"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.21037\/atm-22-1810","article-title":"Single-cell immune ecosystem and metabolism reprogramming imprinted by psoriasis niche","volume":"10","author":"Jiang","year":"2022","journal-title":"Ann Transl Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.11.028","article-title":"Single-cell RNA sequencing of psoriatic skin identifies pathogenic Tc17 cell subsets and reveals distinctions between CD8+ T cells in autoimmunity and cancer","volume":"147","author":"Liu","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.691279","article-title":"HDAC6 and CXCL13 mediate atopic dermatitis by regulating cellular interactions and expression levels of miR-9 and SIRT1","volume":"12","author":"Kwon","year":"2021","journal-title":"Front Pharmacol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1646669","article-title":"Unraveling the role of chemokines in cutaneous T-cell lymphoma: expression levels at different stages","volume":"16","author":"Guglielmo","year":"2025","journal-title":"Front Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-0602","article-title":"CXCL13 is highly produced by S\u00e9zary cells and enhances their migratory ability via a synergistic mechanism involving CCL19 and CCL21 chemokines","volume":"68","author":"Picchio","year":"2008","journal-title":"Cancer Res"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-024-02018-1","article-title":"Cutaneous T cell lymphoma atlas reveals Malignant TH2 cells supported by a B cell-rich tumor microenvironment","volume":"25","author":"Li","year":"2024","journal-title":"Nat Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019000765","article-title":"Prolonged survival with the early use of a novel extracorporeal photopheresis regimen in patients with S\u00e9zary syndrome","volume":"134","author":"Gao","year":"2019","journal-title":"Blood"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102679","article-title":"Real-life efficacy of immunotherapy for S\u00e9zary syndrome: a multicenter observational cohort study","volume":"73","author":"Bozonnat","year":"2024","journal-title":"EClinicalMedicine"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-07-2378","article-title":"Localization of iron metabolism\u2013related mRNAs in rat liver indicate that HFE is expressed predominantly in hepatocytes","volume":"103","author":"Zhang","year":"2004","journal-title":"Blood"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.32.0630","article-title":"Clinical end points and response criteria in mycosis fungoides and S\u00e9zary syndrome: A consensus statement of the international society for cutaneous lymphomas, the United States cutaneous lymphoma consortium, and the cutaneous lymphoma task force of the European organisation for research and treatment of cancer","volume":"29","author":"Olsen","year":"2011","journal-title":"J Clin Oncol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2023.113343","article-title":"EORTC consensus recommendations for the treatment of mycosis fungoides\/S\u00e9zary syndrome - Update 2023","volume":"195","author":"Latzka","year":"2023","journal-title":"Eur J Cancer Oxf Engl 1990"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020009655","article-title":"Integrated genomic analyses of cutaneous T-cell lymphomas reveal the molecular bases for disease heterogeneity","volume":"138","author":"Park","year":"2021","journal-title":"Blood"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-21-4437","article-title":"Single-cell RNA sequencing unveils the clonal and transcriptional landscape of cutaneous T-cell lymphomas","volume":"28","author":"Gaydosik","year":"2022","journal-title":"Clin Cancer Res"},{"key":"B28","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1038\/s41419-022-05323-5","article-title":"Single-cell analyses reveal novel molecular signatures and pathogenesis in cutaneous T cell lymphoma","volume":"13","author":"Xue","year":"2022","journal-title":"Cell Death Dis"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1804103\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T06:02:36Z","timestamp":1775800956000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1804103\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,10]]},"references-count":28,"alternative-id":["10.3389\/fimmu.2026.1804103"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1804103","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,10]]},"article-number":"1804103"}}